Exposure to particulate matter increases pyocyanin production in Pseudomonas aeruginosa

L. Miyashita (LONDON, United Kingdom)

Source: International Congress 2017 – How can microbiology and translational research help physicians?
Session: How can microbiology and translational research help physicians?
Session type: Poster Discussion
Number: 3321
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Miyashita (LONDON, United Kingdom). Exposure to particulate matter increases pyocyanin production in Pseudomonas aeruginosa. 3321

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pseudomonas aeruginosa and cyanide production
Source: Eur Respir J 2011; 37: 482-483
Year: 2011


Pseudomonas aerugenosa sensitivity changes to antibiotics under the influence of dissolved ozone
Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis
Year: 2011

Particulate matter (PM10) alters the virulence of pseudomonas aeruginosa strain PA01
Source: Annual Congress 2013 –Interesting cases of respiratory infections
Year: 2013

Variation in hydrogen cyanide production between different strains of Pseudomonas aeruginosa
Source: Eur Respir J 2011; 38: 409-414
Year: 2011



Cigarette smoke extract (CSE) alters the secretion profile of the Pseudomonas aeruginosa strain PA14
Source: Annual Congress 2012 - Prognosis and outcome of respiratory infections
Year: 2012


Mechanisms of induction of neutrophil apoptosis by the pseudomonas aeruginosa exotoxin pyocyanin
Source: Eur Respir J 2004; 24: Suppl. 48, 107s
Year: 2004

Silica nanoparticles enhance mortality and increase lung permeability during Pseudomonas aeruginosa infection
Source: Lung Science Conference 2015
Year: 2015




Effects of erythromycin on Pseudomonas aeruginosa adherence to collagen and morphology in vitro
Source: Eur Respir J 2003; 21: 401-406
Year: 2003



Increased airway iron as a potential factor in the persistence of Pseudomonas aeruginosa infection in cystic fibrosis
Source: Eur Respir J 2007; 30: 286-292
Year: 2007



Dental units as infection sources of Pseudomonas aeruginosa
Source: Eur Respir J 2008; 32: 1122-1123
Year: 2008


The impact of testosterone on Pseudomonas aeruginosa pathogenicity and antimicrobial susceptibility
Source: International Congress 2018 – Mechanisms of respiratory infection
Year: 2018

Volatile organic compounds emitted by pseudomonas aeruginosa and aspergillus fumigatus mono-cultures and in co-culture
Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous
Year: 2015


Human airway epithelial cell response to Pseudomonas aeruginosa virulence factors preceded or not by Staphylococcus aureus
Source: Eur Respir J 2006; 28: Suppl. 50, 191s
Year: 2006

Effects of subinhibitory concentrations of antibiotics on the biofilm formation of pseudomonas aeruginosa
Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis
Year: 2011

Targeting iron uptake to control Pseudomonas aeruginosa infections in cystic fibrosis
Source: Eur Respir J 2013; 42: 1723-1736
Year: 2013



Baicalin inhibits biofilm formation, attenuates the quorum sensing-controlled virulence and enhances Pseudomonas aeruginosa clearance in vivo
Source: Virtual Congress 2021 – Back to infection basics
Year: 2021

Antimicrobial activity of N-acetylcysteine against Stenotrophomonas maltophilia and Burkholderia cepacia complex grown in planktonic phase and in biofilm
Source: International Congress 2017 – How can microbiology and translational research help physicians?
Year: 2017


Bacterial cyanogenesis occurs in the cystic fibrosis lung
Source: Eur Respir J 2008; 32: 329-333
Year: 2008



Host response to transmissible Pseudomonas aeruginosa
Source: Eur Respir J 2004; 23: 493-494
Year: 2004


Exploring the susceptibility of P. aeruginosa biofilms in human mucus towards tobramycin treatment
Source: International Congress 2017 – Cystic fibrosis: clinical issues
Year: 2017